Laboratory research team reviewing samples in a life sciences facility

Pharma and Life Sciences

Patient Access and Disease Management

Turning an access objective into an executable pathway — from evidence planning to patient navigation.

Discuss an Access Mandate

Capabilities

Programme Capabilities

Structured design and delivery across the patient access and disease management lifecycle.

Government Access and Reimbursement Pathway Support

Evidence planning, stakeholder engagement and submission support with government and payer institutions.

Patient Access Programme Design

Translating access approvals into workable delivery models for the local market.

Patient Navigation and Case Management

From eligibility confirmation to clinical referral, treatment initiation and adherence.

Treatment Initiation and Adherence Support

Structured reminders, coordination and clinical escalation where required.

Corporate Disease Activation

Reaching working populations through employer-facilitated screening programmes.

Programme Intelligence and Reporting

Reach, identification, navigation and adherence — reported for sponsors and regulators.

Programme Flow

From Access Objective to Patient Outcome

From access planning to measurable patient programme delivery.

01
Access Planning
Evidence, stakeholder and reimbursement strategy
02
Programme Design
Patient pathway, eligibility and delivery model
03
Navigation and Management
Patient identification, referral and case management
04
Reporting
Programme outcomes and intelligence for sponsors

Compliance and Regulatory Standards

Programmes are designed around applicable medical, legal and regulatory requirements. Preventra does not promote prescription medicines to the public or guarantee government decisions.

Explore how Preventra could support your access mandate.

At the intersection of market access, patient support and programme delivery.

Discuss an Access Mandate